Top compounds associated with response to NUDCD2


Feature Type Standardized
Nominal ANOVA
mRNA linifanib GDSC1000 pan-cancer AAC -0.09 0.01
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.086 0.01
mRNA BRD-K48334597 CTRPv2 pan-cancer AAC -0.18 0.01
mRNA KIN001-236 GDSC1000 pan-cancer AAC -0.085 0.01
mRNA BRD-M00053801 CTRPv2 pan-cancer AAC 0.12 0.01
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.091 0.01
mRNA Camptothecin GDSC1000 pan-cancer AAC 0.086 0.01
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.087 0.01
mRNA FH535 GDSC1000 pan-cancer AAC 0.087 0.02
mRNA Tipifarnib GDSC1000 pan-cancer AAC 0.089 0.02
Download CSV